Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 174 results found. Search for [ Zydus coronavirus vaccine ]

Results 100 to 120 of 174
BusinessToday.In
July 15, 2020
Stock Market Highlights on July 15: Infosys, Axis Bank, Tech Mahindra, Bajaj Finance, Tata Steel, HCL Tech and IndusInd Bank were among the other gainers on Sensex. On the other hand, Bharti Airtel, ITC and Kotak Bank were the laggards


Mudit Kapoor and Ashish Pandey
New Delhi, July 14, 2020
Sun Pharma, Dr Reddy's Laboratories, Cipla, Torrent Pharmaceuticals, Lupin and Cadila Healthcare have given over 50 per cent return since January 30 when the first coronavirus case was reported


BusinessToday.In
July 13, 2020
Bharat Biotech is developing the vaccine in collaboration with the ICMR. It has started human trials on its vaccine candidate, 'Covaxin', which is India's first indigenous COVID-19 vaccine. It is working to develop an initial capacity of 200 million vials of the vaccine


Reuters
July 12, 2020
Coronavirus vaccine news update: China's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries have agreed to work with it


E Kumar Sharma
July 11, 2020
Coronavirus: Biocon founder and chairperson Kiran Mazumdar Shaw says that in a matter of about 120 days the company has moved from applying for commencement of trials on coronavirus patients to getting the final approval for commercialisation


BusinessToday.In
July 11, 2020
Coronavirus vaccine: The panel was chaired by Congress leader Jairam Ramesh, apart from six other members. It was conveyed to the panel that a coronavirus vaccine could only be available by early next year


BusinessToday.In
July 10, 2020
The Chinese embassy in Kazakhstan has issued a warning about an unknown pneumonia that is sweeping through the country. More than 600 people have died of the disease in June


BusinessToday.In
July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months


BusinessToday.In
July 9, 2020
Coronavirus vaccine: SII CEO Adar Poonawala has stated that he has jumpstarted the production of four different coronavirus vaccine candidates


BusinessToday.In
New Delhi, July 8, 2020
Modi last month had announced that PMGKAY will be extended till November-end. Extension of the scheme for another 5 months will cost the government Rs 90,000 crore, PM Modi had also said


BusinessToday.In
July 8, 2020
This year's parliament session is crucial since the country is grappling with rising COVID-19 cases. To maintain social distancing in both the Houses, speaker gallery, chairmen's gallery and visitors' gallery may be used for sitting arrangement of MPs


Dipak Mondal
July 8, 2020
The GST intelligence unit has said that some of the sugar mills and distilleries are engaged in manufacturing and supplying alcohol-based hand sanitisers and are misclassifying them as items under HSN Code 3004, which are taxed at 12 per cent under GST


BusinessToday.In
July 8, 2020
Coronavirus vaccine update: Twelve hospitals have been chosen for COVAXIN trials in the country. Bharat Biotech's COVAXIN is undergoing quality and safety tests before the doses are administered to volunteers


BusinessToday.In
July 7, 2020
Poonawalla also said that SII will talk about it only when the vaccine is in Phase 3 trials


BusinessToday.In
July 7, 2020
The Central Drug Standard Control Organisation--the office of Drug Controller General of India--has granted permission to initiate Phase-1 and Phase-2  clinical trial of Covaxin. A total of 12 institutes have been selected to conduct clinical trials for Covaxin


BusinessToday.In
July 6, 2020
The company said it will conduct a study to evaluate the efficacy and safety of Desidustat tablets for the management of COVID-19 patients


Joe C Mathew
July 5, 2020
A Vigyan Prasar article claimed that none of the coronavirus vaccines under development around the world, including India, would be available for mass use before 2021; PIB omitted this warning while carrying this article on its portal


BusinessToday.In
July 4, 2020
ICMR assured that the fast-tracked vaccine development process adheres to globally accepted norms while negating hindrances due to red tape and \"slow file movement\"


PB Jayakumar
New Delhi, July 3, 2020
Industry experts say this could be only an aspirational target and directive to speed up the trials, than a realistic move to get the vaccine launched within one and a half months


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed


PAGES 6 OF 9  6789